Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
Sponsor: University of Minnesota
This PHASE1/PHASE2 trial investigates Kidney Transplant Failure and Rejection and is currently completed. University of Minnesota leads this study, which shows 10 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
Status: Enrolling By Invitation → Completed
-
Jan 2021 — May 2021 [monthly]
Enrolling By Invitation PHASE1_PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Enrolling By Invitation PHASE1_PHASE2
▶ Show 5 earlier versions
-
Nov 2019 — Dec 2019 [monthly]
Enrolling By Invitation PHASE1_PHASE2
-
Jun 2019 — Nov 2019 [monthly]
Enrolling By Invitation PHASE1_PHASE2
-
Jul 2018 — Jun 2019 [monthly]
Enrolling By Invitation PHASE1_PHASE2
Status: Not Yet Recruiting → Enrolling By Invitation
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .